Article Text

Download PDFPDF
Capecitabine: guaranteed access in adjuvant treatment of breast cancer

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Twitter @anaicp, @lvilpin1

  • Contributors AICP designed the study and made primary contributions to data collection. LVP, CASF and IFS assisted with data collection. Guarantor: AICP.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.